Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network
暂无分享,去创建一个
B. Kégl | R. Busa-Fekete | C. Pál | B. Papp | Balázs Szappanos | Bálint Csörgő | Gergely Fekete | Viktória Lázár | M. Hrtyan | Á. Nyerges | B. Horváth | I. Nagy | Ádám Györkei | Balázs Bogos | Réka Spohn | Orsolya Méhi | Andrea Vörös | B. Csörgő | Balázs Papp | Csaba Pál
[1] Michelle S. Scott,et al. Chemogenomic profiling predicts antifungal synergies , 2009, Molecular systems biology.
[2] Marcelo Kallmann,et al. Designing Antibiotic Cycling Strategies by Determining and Understanding Local Adaptive Landscapes , 2013, PloS one.
[3] R. Hancock,et al. Mutator Genes Giving Rise to Decreased Antibiotic Susceptibility in Pseudomonas aeruginosa , 2008, Antimicrobial Agents and Chemotherapy.
[4] Igor Zwir,et al. Dissecting the PhoP regulatory network of Escherichia coli and Salmonella enterica. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Fukuda,et al. An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus , 2010, Antimicrobial Agents and Chemotherapy.
[6] Peter L. Freddolino,et al. Bacterial Adaptation through Loss of Function , 2013, PLoS genetics.
[7] A. Ivens,et al. Clinically Relevant Mutant DNA Gyrase Alters Supercoiling, Changes the Transcriptome, and Confers Multidrug Resistance , 2013, mBio.
[8] A. C. Davison,et al. Statistical models: Name Index , 2003 .
[9] P. Miller,et al. Bacterial uptake of aminoglycoside antibiotics. , 1987, Microbiological reviews.
[10] M. Klein,et al. THE ROLE OF BACTERIAL RESISTANCE IN ANTIBIOTIC SYNERGISM AND ANTAGONISM , 1953, Journal of bacteriology.
[11] R. Proctor,et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections , 2006, Nature Reviews Microbiology.
[12] Tamás Fehér,et al. Scarless engineering of the Escherichia coli genome. , 2008, Methods in molecular biology.
[13] Haixu Tang,et al. Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing , 2012, Proceedings of the National Academy of Sciences.
[14] C. I. Bliss. THE TOXICITY OF POISONS APPLIED JOINTLY1 , 1939 .
[15] Andrew C. Pawlowski,et al. The Comprehensive Antibiotic Resistance Database , 2013, Antimicrobial Agents and Chemotherapy.
[16] M. Vulić,et al. Role of Global Regulators and Nucleotide Metabolism in Antibiotic Tolerance in Escherichia coli , 2008, Antimicrobial Agents and Chemotherapy.
[17] D. R. McCalla,et al. Genetics of Nitrofurazone Resistance in Escherichia coli , 1978, Journal of bacteriology.
[18] I. Matic,et al. Intermediate Mutation Frequencies Favor Evolution of Multidrug Resistance in Escherichia coli , 2005, Genetics.
[19] Roy Kishony,et al. Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance , 2013, Nature Reviews Genetics.
[20] Farren J. Isaacs,et al. Programming cells by multiplex genome engineering and accelerated evolution , 2009, Nature.
[21] S. Levy,et al. The mar regulon: multiple resistance to antibiotics and other toxic chemicals. , 1999, Trends in microbiology.
[22] C. Steinbeck,et al. Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics. , 2006, Current pharmaceutical design.
[23] Ramunas Stepanauskas,et al. Co-selection of antibiotic and metal resistance. , 2006, Trends in microbiology.
[24] R. Kishony,et al. Antibiotic interactions that select against resistance , 2007, Nature.
[25] B. C. Wong,et al. Sequential Inactivation of rdxA (HP0954) and frxA (HP0642) Nitroreductase Genes Causes Moderate and High-Level Metronidazole Resistance in Helicobacter pylori , 2000, Journal of bacteriology.
[26] N. Krogan,et al. Phenotypic Landscape of a Bacterial Cell , 2011, Cell.
[27] Balázs Papp,et al. Systems-biology approaches for predicting genomic evolution , 2011, Nature Reviews Genetics.
[28] Patrice Courvalin,et al. Synergism between β-Lactams and Glycopeptides against VanA-Type Methicillin-Resistant Staphylococcus aureus and Heterologous Expression of the vanA Operon , 2006, Antimicrobial Agents and Chemotherapy.
[29] Andrew R. Leach,et al. An Introduction to Chemoinformatics , 2003 .
[30] B. Kégl,et al. Bacterial evolution of antibiotic hypersensitivity , 2013, Molecular systems biology.
[31] S. Levy,et al. Molecular Mechanisms of Antibacterial Multidrug Resistance , 2007, Cell.
[32] Remy Chait,et al. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection , 2011, Nature Genetics.
[33] J. Collins,et al. How antibiotics kill bacteria: from targets to networks , 2010, Nature Reviews Microbiology.
[34] D. Andersson. The biological cost of mutational antibiotic resistance: any practical conclusions? , 2006, Current opinion in microbiology.
[35] R. Kishony,et al. Functional classification of drugs by properties of their pairwise interactions , 2006, Nature Genetics.
[36] M. Niederweis,et al. Multidrug Resistance of a Porin Deletion Mutant of Mycobacterium smegmatis , 2004, Antimicrobial Agents and Chemotherapy.
[37] Trevor Hastie,et al. Statistical Models in S , 1991 .
[38] Alison K. Hottes,et al. Genetic Architecture of Intrinsic Antibiotic Susceptibility , 2009, PloS one.
[39] H. Juan. Small Colony Variants: a Pathogenic Form of Bacteria that Facilitates Persistent and Recurrent Infections , 2009 .
[40] Qun Ma,et al. Cryptic prophages help bacteria cope with adverse environments , 2010, Nature communications.
[41] F. Lépine,et al. Active Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-Limited Bacteria , 2011, Science.
[42] Chang-Xing Ma,et al. Fluctuation AnaLysis CalculatOR: a web tool for the determination of mutation rate using Luria-Delbrück fluctuation analysis , 2009, Bioinform..
[43] M. R. Brown,et al. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response , 1990, Antimicrobial Agents and Chemotherapy.
[44] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[45] H. Nikaido,et al. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants , 1996, Journal of bacteriology.
[46] A. Walmsley,et al. Microbial and viral drug resistance mechanisms. , 2002, Trends in microbiology.
[47] L. Piddock. Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria , 2006, Clinical Microbiology Reviews.
[48] Egon L. Willighagen,et al. The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo-and Bioinformatics , 2003, J. Chem. Inf. Comput. Sci..
[49] Morten Otto Alexander. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. , 2016 .
[50] W. Szybalski,et al. Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics. , 1954, Journal of bacteriology.
[51] A. F. Bennett,et al. The Molecular Diversity of Adaptive Convergence , 2012, Science.
[52] D. Hughes,et al. Hyper-susceptibility of a fusidic acid-resistant mutant of Salmonella to different classes of antibiotics. , 2005, FEMS microbiology letters.
[53] Nevan J Krogan,et al. Cross-species chemogenomic profiling reveals evolutionarily conserved drug mode of action , 2010, Molecular systems biology.
[54] G. Bell,et al. The evolution of a pleiotropic fitness tradeoff in Pseudomonas fluorescens. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[55] M. Shumkov,et al. Polyamines reduce oxidative stress in Escherichia coli cells exposed to bactericidal antibiotics. , 2012, Research in microbiology.
[56] R. Lenski,et al. The population genetics of ecological specialization in evolving Escherichia coli populations , 2000, Nature.
[57] D. Futuyma,et al. The Evolution of Ecological Specialization , 1988 .
[58] A. Oliver,et al. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. , 2000, Science.
[59] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[60] Ilias Tagkopoulos,et al. Evolutionary potential, cross-stress behavior and the genetic basis of acquired stress resistance in Escherichia coli , 2013, Molecular systems biology.